Characterisation of immune responses in type I interferon associated diseases

Download
2016
Gül, Ersin
Type-I interferonopathies are a heterogeneous group of diseases arising from deregulation in nucleic acid sensing pathways, leading to constitutive type-I interferon release and pathology. DNA damage, if not repaired can also potentially activate such pathways. To test the hypothesis that 2 different DNA damage repair and immune deficiencies, Ataxia telangiectasia (AT) and Artemis deficiency could suffer from clinical manifestations associated with elevated type I IFN response, we compared the immune status of AT and Artemis deficient patients to healthy controls and to two patients with confirmed type I interferonopathies (one SAVI (STING-associated vasculopathy with onset in infancy) and one TREX-1 deficient patient diagnosed with Aicardi-Goutières Syndrome (AGS)). Our results demonstrated that type-I and III interferon signatures were elevated in plasma and peripheral blood cells of AT and Artemis deficient patients. Specifically, compared to healthy controls, circulating IP-10 (9- and 14-fold), IFN (5- and 7-fold) and IFN1 (4- and 5-fold) concentrations were significantly higher in AT and Artemis deficient patients, respectively. Moreover, AT and Artemis deficient peripheral blood mononuclear cells (PBMC) secreted ~4- and ~5 fold more IFN-α than healthy controls in the absence of any stimulation. This exaggerated response was still maintained when cells were stimulated with the STING ligand 2’3’-cGAMP (6- and 31-fold more IFN secretion from AT and Artemis deficient cells). Measurement of phosphorylated STAT1 concentrations within PBMCs revealed elevated levels in AT and Artemis deficient patients with respect to healthy controls. These results suggest that AT and Artemis deficient patients have immune features consistent with elevated type I IFN signature. Next, we hypothesized that aberrant IFN production could activate neutrophils and contribute to tissue damage. Herein, we show for the first time that neutrophils of AT, Artemis deficient and SAVI patients spontaneously produced neutrophil extracellular traps (NETs). Consistent with neutrophil activation, plasma elastase was significantly higher in all tested patient groups suggesting that neutrophils might be contributing to tissue damage in classical and proposed type-I interferonopathies.

Suggestions

CpG RNA: identification of novel single-stranded RNA that stimulates human CD14+CD11c+ monocytes.
Sugiyama, T; Gürsel, Mayda; Takeshita, F; Coban, C; Conover, J; Kaisho, T; Akira, S; Klinman, DM; Ishii, KJ (The American Association of Immunologists, 2005-02-15)
Synthetic immunostimulatory nucleic acids such as CpG DNA are being harnessed therapeutically as vaccine adjuvants, anticancer or antiallergic agents. Efforts to identify nucleic acid-based agents capable of more specifically modulating the immune system are being developed. The current study identifies a novel class of single-stranded oligoribonucleotides (ORN) containing unmethylated CpG motifs and a poly(G) run at the 3 end (CpG ORN) that directly stimulate human CD14 CD11c monocytes but not dendritic ...
Cutting edge: Role of toll-like receptor 9 in CpG DNA-induced activation of human cells
Takeshita, F; Leifer, CA; Gursel, I; Ishii, KJ; Takeshita, S; Gürsel, Mayda; Klinman, DM (The American Association of Immunologists, 2001-10-01)
Unmethylated CpG motifs present in bacterial DNA stimulate a rapid and robust innate immune response. Human cell lines and PBMC that recognize CpG DNA express membrane-bound human Toll-like receptor 9 (hTLR9). Cells that are not responsive to CpG DNA become responsive when transfected with hTLR9. Expression of hTLR9 dramatically increases uptake of CpG (but not control) DNA into endocytic vesicles. Upon cell stimulation, hTLR9 and CpG DNA are found in the same endocytic vesicles. Cells expressing hTLR9 are ...
CpG oligodeoxynucleotides protect normal and SIV-infected macaques from Leishmania infection.
Verthelyi, D; Gürsel, Mayda; Kenney, RT; Lifson, JD; Liu, S; Mican, J; Klinman, DM (The American Association of Immunologists, 2003-05-01)
Oligodeoxynucleotides containing CpG motifs (CpG ODNs) mimic microbial DNA and activate effectors of the innate immune response, which limits the spread of pathogens and promotes an adaptive immune response. CpG ODNs have been shown to protect mice from infection with intracellular pathogens. Unfortunately, CpG motifs that optimally stimulate humans are only weakly active in mice, mandating the use of nonhuman primates to monitor the activity and safety of "human" CpG ODNs in vivo. This study demonstrates t...
Differential activation of immune cells by commensal versus pathogen-derived bacterial RNA
Özcan, Mine; Gürsel, Mayda; Department of Biology (2014)
Immunological mechanisms contributing to distinguishing signals derived from commensal versus pathogenic bacteria is an active area of research and recent evidence suggests that commensal and pathogens may express different variants of pathogen associated molecular patterns (PAMP). In this thesis, we propose that as a major member of PAMP, bacterial RNAs derived from commensal and pathogens may have distinct immunostimulatory activities due to differentially recognition by the host immune system. In order t...
Differential immune activation following encapsulation of immunostimulatory CpG oligodeoxynucleotide in nanoliposomes.
Erikçi, E; Gürsel, Mayda; Gürsel, I (2011-02-01)
The immunogenicity of a vaccine formulation is closely related to the effective internalization by the innate immune cells that provide prolonged and simultaneous delivery of antigen and adjuvant to relevant antigen presenting cells. Endosome associated TLR9 recognizes microbial unmethylated CpG DNA. Clinical applications of TLR9 ligands are significantly hampered due to their pre-mature in vivo digestion and rapid clearance. Liposome encapsulation is a powerful tool to increase in vivo stability as well as...
Citation Formats
E. Gül, “Characterisation of immune responses in type I interferon associated diseases,” M.S. - Master of Science, Middle East Technical University, 2016.